AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Convatec Group PLC

Director's Dealing Aug 29, 2025

4959_dirs_2025-08-29_61374746-ca82-4035-8ece-533e41b5e86a.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 2247X

Convatec Group PLC

29 August 2025

29 August 2025

Convatec Group Plc

("Convatec" or "the Company")

Director/PDMR Shareholding

Purchase of Ordinary Shares

The Company has been notified of the following transactions in relation to Persons Discharging Managerial Responsibility ("PDMR") in respect of ordinary shares of 10 pence each in the Company ("Shares").

On 28 August 2025, Jonny Mason, Interim Chief Executive Officer, purchased 50,000 Shares at an average price of 234.81 pence per Share.

On the same day, Fiona Ryder, Interim Chief Financial Officer purchased 21,263 Shares at an average price of 233.96 pence per Share.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Jonny Mason

2

Reason for the notification

a)

Position/status

Interim Chief Executive Officer and PDMR

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Convatec Group Plc

b)

LEI

213800LS272L4FIDOH92

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary share of 10p each in Convatec Group Plc

Identification code

GB00BD3VFW73

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Price(s) Volume(s)
£2.3481 50,000

d)

Aggregated information

- Aggregated volume

N/A - single transaction

- Price

e)

Date of the transaction

28 August 2025

f)

Place of the transaction

London Stock Exchange

Details of the person discharging managerial responsibilities / person closely associated

Name

Fiona Ryder

Reason for the notification

Position/status

Interim Chief Financial Officer and PDMR

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Convatec Group Plc

LEI

213800LS272L4FIDOH92

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

Ordinary share of 10p each in Convatec Group Plc

Identification code

GB00BD3VFW73

Nature of the transaction

Purchase of Ordinary Shares

Price(s) and volume(s)

Price(s) Volume(s)
£2.3396 21,263

Aggregated information

- Aggregated volume

N/A - single transaction

- Price

Date of the transaction

28 August 2025

Place of the transaction

London Stock Exchange

Contacts

The person responsible for making this announcement is James Kerton, Company Secretary, Convatec Group plc: [email protected]

Media : [email protected]

Investor Relations : [email protected]

Convatec Group Plc's LEI code is 213800LS272L4FIDOH92

Classification: 2.2 Information disclosed under article 19 of the Market Abuse Regulation

About Convatec

Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. With more than 10,000 colleagues, we provide our products and services in around 90 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. Convatec's revenues in 2024 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more please visit http://www.convatecgroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFIFITTDIAFIE

Talk to a Data Expert

Have a question? We'll get back to you promptly.